secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2023-07-20T23:59:59+00:00
Accession:  0001213900-23-058331
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea announces $4M tender offer for common stock at $0.70/share, expected Q3 2023
--------------------------------------------------------------------------------

- Board authorized $4.0M tender offer to repurchase up to ~5.7M shares at $0.70 per share in cash.
- Tender offer expected to close in the third quarter of 2023.
- Executive officers and directors will not tender any shares in the offer.
- If oversubscribed, shares will be accepted on a pro rata basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/0001213900-23-058331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/ea182059-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-058331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer